Cargando…
The Potential Role of Kallistatin in the Development of Abdominal Aortic Aneurysm
Abdominal aortic aneurysm (AAA) is a vascular condition that causes permanent dilation of the abdominal aorta, which can lead to death due to aortic rupture. The only treatment for AAA is surgical repair, and there is no current drug treatment for AAA. Aortic inflammation, vascular smooth muscle cel...
Autores principales: | Li, Jiaze, Krishna, Smriti Murali, Golledge, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000709/ https://www.ncbi.nlm.nih.gov/pubmed/27529213 http://dx.doi.org/10.3390/ijms17081312 |
Ejemplares similares
-
Kallistatin limits abdominal aortic aneurysm by attenuating generation of reactive oxygen species and apoptosis
por: Krishna, Smriti Murali, et al.
Publicado: (2021) -
Risk Factors and Mouse Models of Abdominal Aortic Aneurysm Rupture
por: Murali Krishna, Smriti, et al.
Publicado: (2020) -
Pathogenesis and management of abdominal aortic aneurysm
por: Golledge, Jonathan, et al.
Publicado: (2023) -
Cohort Study Examining the Association of Optimal Blood Pressure Control at Entry With Infrarenal Abdominal Aortic Aneurysm Growth
por: Thomas Manapurathe, Diana, et al.
Publicado: (2022) -
Potential of Disease-Modifying Anti-Rheumatic Drugs to Limit Abdominal Aortic Aneurysm Growth
por: Thanigaimani, Shivshankar, et al.
Publicado: (2022)